Sulforaphane pre-treatment protects from oxidative damage, reducing 8-oxo-dG positive cells to the level observed in control animals and preventing loss of parvalbumin-positive cells, thereby preventing schizophrenia-like behaviors (Shirai et al., 2015). The gene discussed is PVALB; the disease is schizophrenia.